Compliance Rate

Compliance Rate 100.0%
Compliant submissions 1
Incompliant submissions 0
Total trials 1

My Organizations' Clinical Trials

Showing 625 of 1329 entries
View as:

Alisertib in Treating Patients With Myelofibrosis or Relapsed or Refractory Acute Megakaryoblastic Leukemia

Phase: N/A Priority: Normal
NCT ID: NCT02530619 Org: User:
Start: 10/09/15 End: 05/31/22 Due: 05/31/23

Behavioral Economics Applications to Geriatrics Leveraging EHRs R33 Trial

Phase: N/A Priority: Normal
NCT ID: NCT04289753 Org: User:
Start: 09/01/20 End: 09/30/22 Due: 09/30/23

Peripheral Stem Cell Transplantation to Prevent Neutropenia in Patients Receiving Chemotherapy for Relapsed or Refractory Non-Hodgkin's Lymphoma

Phase: N/A Priority: Normal
NCT ID: NCT00005787 Org: User:
Start: 09/30/99 End: 01/31/02 Due: 01/31/03

Redesigning Systems to Improve Quality for Hospitalized Patients

Phase: N/A Priority: Normal
NCT ID: NCT03745677 Org: User:
Start: 06/05/18 End: 11/30/22 Due: 11/30/23

Effect of Externally Implantable Tissue Expansion Device on Scar Length

Phase: N/A Priority: Normal
NCT ID: NCT00798798 Org: User:
Start: 04/30/08 End: 10/31/10 Due: 10/31/11

Bone Marrow Transplantation in Treating Patients With Multiple Myeloma, Chronic Phase Chronic Myelogenous Leukemia, or Agnogenic Myeloid Metaplasia

Phase: N/A Priority: Normal
NCT ID: NCT00004181 Org: User:
Start: 10/31/99 End: 08/31/04 Due: 08/31/05

A Pilot Study to Determine the Feasibility, Acceptance, and Effectiveness of In-vitro Maturation in Patients Without IVF Coverage

Phase: N/A Priority: Normal
NCT ID: NCT05793931 Org: User:
Start: 11/16/21 End: 03/01/23 Due: 03/01/24

EAT: A Reliable Eating Assessment Technology for Free-living Individuals

Phase: N/A Priority: Normal
NCT ID: NCT06118528 Org: User:
Start: 09/04/24 End: 10/31/25 Due: 10/31/26

The Effect of Pre-Operative Transversus Abdominis Plane (TAP) Block in the Post Operative Opioid Consumption in Morbid Obese Patients Undergoing Laparoscopic Gastric Bypass Surgery: A Prospective,Randomized, Blinded Study

Phase: N/A Priority: Normal
NCT ID: NCT01075087 Org: User:
Start: 03/31/10 End: 08/31/12 Due: 08/31/13

Vudalimab for the Treatment of Locally Advanced or Metastatic Anaplastic Thyroid Cancer or Hurthle Cell Thyroid Cancer

Phase: N/A Priority: Normal
NCT ID: NCT05453799 Org: User:
Start: 07/21/22 End: 07/15/24 Due: 07/15/25

Cyclophosphamide and Rabbit Antithymocyte Globulin (rATG)/Rituximab in Patients With Systemic Lupus Erythematosus

Phase: N/A Priority: Normal
NCT ID: NCT00278538 Org: User:
Start: 09/23/05 End: 05/31/19 Due: 05/31/20

A Comparison of the Detection of Hypoventilation During Deep Sedation Utilizing Nasal End Title CO@ Versus Transcutaneous CO2 Measurement Techniques

Phase: N/A Priority: Normal
NCT ID: NCT00954733 Org: User:
Start: 06/30/09 End: 08/31/09 Due: 08/31/10

Topical Sildenafil as Pre-Treatment for Hand-Foot Skin Reaction

Phase: N/A Priority: Normal
NCT ID: NCT03229512 Org: User:
Start: 04/11/17 End: 06/04/20 Due: 06/04/21

Impact of NBI on Patients Undergoing Endoscopic Eradication Therapy

Phase: N/A Priority: Normal
NCT ID: NCT03191604 Org: User:
Start: 11/01/17 End: 05/10/19 Due: 05/10/20

Phase I/II Trial of VELCADE Plus Zevalin in Patients With Relapsed or Refractory Follicular Lymphoma

Phase: N/A Priority: Normal
NCT ID: NCT00372905 Org: User:
Start: 07/24/07 End: 07/08/13 Due: 07/08/14

Pembrolizumab and Capecitabine in Treating Patients With Locally Advanced or Metastatic Triple Negative or Hormone-Refractory Breast Cancer That Cannot Be Removed by Surgery

Phase: N/A Priority: Normal
NCT ID: NCT03044730 Org: User:
Start: 05/25/17 End: 05/31/21 Due: 05/31/22

Effect of Alendronate on Bone in People With Chronic Spinal Cord Injury (SCI) Previously Treated With Teriparatide

Phase: N/A Priority: Normal
NCT ID: NCT02195895 Org: User:
Start: 04/30/14 End: 08/05/16 Due: 08/05/17

A Trial of Cooled Radiofrequency Ablation of Medial Branch Nerves for theTreatment of Lumbar Facet Syndrome

Phase: N/A Priority: Normal
NCT ID: NCT02478437 Org: User:
Start: 06/30/15 End: 08/31/18 Due: 08/31/19

Relugolix and Enzalutamide in Combination With Radiation Therapy for the Treatment of Very High Risk Prostate Cancer, OPTIMAL Trial

Phase: N/A Priority: Normal
NCT ID: NCT06499870 Org: User:
Start: 09/06/24 End: 11/19/32 Due: 11/19/33

Pre Operative Transversus Abdominis Plane Block Laparoscopic Gynecological Surgery

Phase: N/A Priority: Normal
NCT ID: NCT01075074 Org: User:
Start: 08/31/10 End: 03/31/11 Due: 03/31/12

Analysis of Blood and Bone Marrow to Detect Residual Disease in Patients With Previously Treated Hairy Cell Leukemia

Phase: N/A Priority: Normal
NCT ID: NCT00005619 Org: User:
Start: 02/29/00 End: 08/31/01 Due: 08/31/02

Opt-IN: Optimization of Remotely Delivered Intensive Lifestyle Treatment for Obesity

Phase: N/A Priority: Normal
NCT ID: NCT01814072 Org: User:
Start: 09/30/13 End: 09/20/17 Due: 09/20/18

Biomarker Analyses in Hepatocellular Carcinoma (HCC) Patients Treated With TheraSphere®

Phase: N/A Priority: Normal
NCT ID: NCT03203837 Org: User:
Start: 07/05/17 End: 01/06/20 Due: 01/06/21

Spatial Orientation and Fiberoptic Intubation Skills in the Novice: A Randomized Controlled Trial

Phase: N/A Priority: Normal
NCT ID: NCT02263300 Org: User:
Start: 10/31/14 End: 03/30/15 Due: 03/30/16

Measuring Patient Engagement in Diabetes Care

Phase: N/A Priority: Normal
NCT ID: NCT02988427 Org: User:
Start: 12/31/16 End: 12/31/16 Due: 12/31/17